Cargando…
Low-dose single-shot COVID-19 mRNA vaccines lie ahead
Autor principal: | Sanders, Niek N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134890/ https://www.ncbi.nlm.nih.gov/pubmed/34015254 http://dx.doi.org/10.1016/j.ymthe.2021.05.003 |
Ejemplares similares
-
Gene patents and personalized medicine - what lies ahead?
por: Chandrasekharan, Subhashini, et al.
Publicado: (2009) -
Immunotherapy resistance: the answers lie ahead – not in front – of us
por: Andrews, Miles C., et al.
Publicado: (2017) -
A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019
por: Evans, Marc, et al.
Publicado: (2019) -
A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019
por: Fleischmann, Roy
Publicado: (2019) -
A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019
por: Menter, Alan, et al.
Publicado: (2019)